Loading…
InnovAge Holding Corp. is projected to rise to $10.86 by 2027, a +46% move from its current price of $7.43. INNV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.26 | $7.43 | $7.61 | +0.04% |
| May 30 | $7.20 | $7.44 | $7.68 | +0.08% |
| May 31 | $7.15 | $7.44 | $7.74 | +0.13% |
| Jun 1 | $7.11 | $7.44 | $7.79 | +0.17% |
| Jun 2 | $7.07 | $7.45 | $7.84 | +0.21% |
| Jun 3 | $7.04 | $7.45 | $7.88 | +0.25% |
| Jun 4 | $7.01 | $7.45 | $7.92 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.01 | $7.45 | $7.92 | +0.29% |
| Week 2 | $6.85 | $7.47 | $8.15 | +0.59% |
| Week 3 | $6.74 | $7.50 | $8.33 | +0.89% |
| Week 4 | $6.65 | $7.52 | $8.50 | +1.18% |
| Week 5 | $6.58 | $7.54 | $8.65 | +1.48% |
| Week 6 | $6.51 | $7.56 | $8.79 | +1.78% |
| Week 7 | $6.45 | $7.58 | $8.92 | +2.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InnovAge Holding Corp. is a healthcare company that manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities.
It operates the Program of All-Inclusive Care for the Elderly (PACE) and offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management.
It serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 1989 and is headquartered in Denver, Colorado.
InnovAge Holding Corp. (INNV) is a healthcare company with a current price of $7.20 and a market capitalization of $977.3M. It is ranked 2551 in market size and visibility among listed assets.
The technical picture shows a bullish tilt, with RSI14 at 40, a 50-day simple moving average of $7.93 and a 200-day simple moving average of $6.20. This coloring is complemented by a near-term support at $7.12 and a resistance at $8.37, framed by a 30-day price range of $6.14 to $8.44.
The multi-year forecast points to a rising price trajectory with an average price path across years, including a 2026 average of $7.20 moving toward higher levels through 2050, with substantial ROIs in later years. The forecast shows a wide potential upside, culminating in a 2050 average of $76.81 and a max of $136.02, with a 966.8 ROI and a bullish sentiment for the long run.
A major floor 26.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.2% below — buyers have tended to step in here.
The nearest ceiling, 12.7% above — a clean break opens room to run.
A major ceiling 42.7% above — clearing it would confirm fresh momentum.
Key INNV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INNV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.37 | Buy | $7.36 | Buy |
| MA 10 | $7.33 | Buy | $7.40 | Buy |
| MA 20 | $7.63 | Sell | $7.55 | Sell |
| MA 50 | $7.88 | Sell | $7.73 | Sell |
| MA 100 | $7.61 | Sell | $7.40 | Buy |
| MA 200 | $6.24 | Buy | $6.59 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.42 | Neutral |
| Stoch RSI (14) | 69.19 | Neutral |
| CCI (20) | -38.67 | Neutral |
| Williams %R (14) | -67.71 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -1.85 | Sell |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 32.29 | Neutral |
| TRIX (15) | -0.35 | Sell |
| Awesome (5,34) | -0.44 | Sell |
| Ultimate (7,14,28) | 53.41 | Neutral |
| Momentum (10) | -0.12 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 7.35 | Buy |
| ADX (14) | 13.42 | Neutral |
| ATR (14) | 0.17 | Info |
30-day range: $6.14 to $8.44.
RSI14 is 40, with SMA50 at $7.93 and SMA200 at $6.20. The stock shows a near-term support at $7.12 and a near-term resistance at $8.37. Overall, the technical picture is described as BULLISH.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.19 | $7.43 | $10.73 | 0% | Neutral | |
| $8.74 | $10.86 | $14.21 | +46% | Bullish | |
| $10.10 | $12.84 | $17.33 | +73% | Bullish | |
| $10.71 | $13.86 | $19.18 | +87% | Bullish | |
| $11.74 | $15.46 | $21.84 | +108% | Bullish | |
| $12.01 | $16.06 | $23.11 | +116% | Bullish | |
| $13.00 | $17.63 | $25.78 | +137% | Bullish | |
| $16.44 | $22.58 | $33.54 | +204% | Bullish | |
| $17.88 | $24.88 | $37.47 | +235% | Bullish | |
| $18.99 | $26.74 | $40.78 | +260% | Bullish | |
| $27.33 | $40.62 | $65.42 | +447% | Bullish | |
| $48.24 | $78.55 | $137.06 | +957% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.19 | $7.43 | $8.75 | +0.00% |
| June 2026 | $6.59 | $7.71 | $9.22 | +3.78% |
| July 2026 | $6.55 | $7.72 | $9.34 | +0.13% |
| August 2026 | $6.61 | $7.83 | $9.56 | +1.46% |
| September 2026 | $6.90 | $8.22 | $10.10 | +4.91% |
| October 2026 | $7.04 | $8.42 | $10.42 | +2.44% |
| November 2026 | $6.97 | $8.37 | $10.42 | -0.56% |
| December 2026 | $7.12 | $8.57 | $10.73 | +2.43% |
Click any year to see its month-by-month INNV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INNV to range from $5.19 to $10.73 through 2026. The $7.43 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The INNV price prediction for 2027 points to an average of $10.86 (low $8.74, high $14.21) — a potential gain of +46% on today's $7.43. Buyers look set to stay in control over this stretch.
In 2028, INNV is projected to trade between $10.10 and $17.33, averaging $12.84 — a potential gain of +73% from today's $7.43. That is up +18% on the projected 2027 average. Momentum favours further upside here.
InnovAge Holding Corp.'s 2029 outlook centres on $13.86, within a $10.71 to $19.18 range. That is up +8% on the projected 2028 average. That marks a +87% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, INNV could reach as high as $21.84, with a base case around $15.46 and support toward $11.74 — roughly +108% from $7.43. Momentum favours further upside here.
Expect INNV to range from $12.01 to $23.11 through 2031. The $16.06 average target implies a +116% move from current prices. That is up +4% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The INNV price prediction for 2032 points to an average of $17.63 (low $13.00, high $25.78) — a potential gain of +137% on today's $7.43. Momentum favours further upside here.
In 2033, INNV is projected to trade between $16.44 and $33.54, averaging $22.58 — a potential gain of +204% from today's $7.43. That is up +28% on the projected 2032 average. Buyers look set to stay in control over this stretch.
InnovAge Holding Corp.'s 2034 outlook centres on $24.88, within a $17.88 to $37.47 range. That is up +10% on the projected 2033 average. That marks a +235% change versus current levels. Momentum favours further upside here.
By 2035, INNV could reach as high as $40.78, with a base case around $26.74 and support toward $18.99 — roughly +260% from $7.43. Buyers look set to stay in control over this stretch.
Expect INNV to range from $27.33 to $65.42 through 2040. The $40.62 average target implies a +447% move from current prices. That is up +52% on the projected 2035 average. Momentum favours further upside here.
The INNV price prediction for 2050 points to an average of $78.55 (low $48.24, high $137.06) — a potential gain of +957% on today's $7.43. Buyers look set to stay in control over this stretch.
Investing $1,000 in INNV today (≈ 134.589502 INNV) could be worth
$10,572.36
+$9,572.36 (+957%) by 2050 · US Dollar
Based on the average projected INNV price of $78.55 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INNVwould be worth at today's price.
$1,000 invested in INNV on May 27, 2025 (≈ 247.524755 INNV) would be worth
$1,839.11
+$839.11 (+83.9%) today · 1.84× · US Dollar
Based on a INNV entry price of $4.04 vs. today's $7.43.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.51 | $989.35 | -1.1% |
| 1 month ago | $8.09 | $918.42 | -8.2% |
| 3 months ago | $9.3 | $798.92 | -20.1% |
| 6 months ago | $5.28 | $1,407.2 | +40.7% |
| 1 year ago | $4.04 | $1,839.11 | +83.9% |
| All time (5.0y) ago | $21.89 | $339.42 | -66.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INNV forecast.
Our base-case forecast reaches $15.00 around 2030.
Implied market cap at $15.00: $2.04B
The year-by-year forecast shows a rising trajectory from 2026 onward. In 2027, the avg is $10.60 with a min of $8.50 and a max of $13.95, a ROI of 47.2 and a bullish sentiment. By 2028 the avg rises to $12.54 (min $9.82, max $17.05; ROI 74.2) and in 2029 to $13.59 (min $10.44, max $18.95; ROI 88.8; bullish).
In 2030 the avg is $15.01 (min $11.33, max $21.39; ROI 108.5; bullish), and by 2031–2035 the forecast continues higher: 2031 avg $15.58 (min $11.57, max $22.62; ROI 116.4), 2032 avg $17.24 (min $12.61, max $25.46; ROI 139.4), 2033 avg $22.07 (min $15.92, max $33.09; ROI 206.5), 2034 avg $24.26 (min $17.27, max $36.91; ROI 237), 2035 avg $26.20 (min $18.42, max $40.39; ROI 263.8).
The longer horizon shows substantial gains: 2040 avg $39.66 (min $26.33, max $64.67; ROI 450.8), and 2050 avg $76.81 (min $46.29, max $136.02; ROI 966.8). Across these years the sentiment is consistently BULLISH, reflecting an expectation of meaningful upside over the long term.
Tap a question to reveal the answer.
2030 min: $11.33; avg: $15.01; max: $21.39; ROI: 108.5; sentiment: BULLISH.
2027 min: $8.50; avg: $10.60; max: $13.95; ROI: 47.2; sentiment: BULLISH.
Yes. The 2050 forecast max is $136.02 with an avg of $76.81 and a min of $46.29; ROI: 966.8; sentiment: BULLISH.
Current price: $7.20; Market cap: $977.3M; Rank: 2551.
30-day range: $6.14 to $8.44; support: $7.12; resistance: $8.37.
InnovAge Holding Corp. Community Discussion
0Share your InnovAge Holding Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.